RxDoctor Payments Data

Flerida Tan

Family · Mays Landing, NJNPI 1316479991

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.9% of the total across 348 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,148, 9.8 times the $220 reported in 2021. Among family clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,492in general payments, 2019–2025

Across 348 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$666
  • Novartis$547
  • AbbVie$539
  • Lilly USA, LLC$537
  • UCB, Inc.$459
  • E.r. Squibb & Sons, L.L.C.$429
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,10293%
  • Education$3907%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,492 in reported general payments places this provider in the 95th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey →

Medicare billing

Part B allowed, 2024
$90,119
Medicare patients
404
Services billed
1,560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$47,706
Clobetasol Propionate192$8,580
Ketoconazole384$6,711
Calcipotriene30$5,806
Ammonium Lactate250$4,658
Tretinoin63$3,240
Metronidazole74$3,071
Azelaic Acid28$2,566
Tacrolimus17$2,430
Fluorouracil34$2,421
Mometasone Furoate94$2,276
Clindamycin Phosphate82$2,257
Triamcinolone Acetonide151$1,897
CiclopiroxCiclopirox Olamine18$1,026
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip36$955

Paid to pharmacies, not to this prescriber.

Other family in Mays Landing

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →